Samra Turajlić
Medical oncologist and cancer-evolution researcher who leads the TRACERx Renal study and now directs the Cancer Research UK Manchester Institute.
Overview
Samra Turajlić is Director of the Cancer Research UK Manchester Institute, part of the University of Manchester. A medical oncologist specialising in kidney cancer and melanoma, she led the TRACERx Renal programme that mapped the evolutionary trajectories of clear-cell renal cell carcinoma from primary tumour to metastasis. Her appointment as Director is announced on the Institute's website.
Pages like this
not linked directly; found by shared links- PersonTim Somervaille
Shares Cancer Research UK Manchester Institute and the tag clinician-scientist.
- PersonAntonio Rosato
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonRana McKay
Shares Renal cell carcinoma and the tags clinician-scientist, kidney cancer.
- PersonSusana Puig
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonKenneth K. Tanabe
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonJanja Ocvirk
Shares Melanoma and the tags leadership, clinician-scientist.
- PersonGeorges-Pascal Haber
Shares Renal cell carcinoma and the tags leadership, clinician-scientist.
- PersonMark Middleton
Shares Melanoma and the tags leadership, clinician-scientist.